Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations of Securities Fraud - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had reportedly fallen sharply, contradicting the company's public statements about sales growth and market position [5][4]. Stock Price Decline - On October 23, 2025, Integer revised its 2025 sales guidance down to a range of $1.840 billion to $1.854 billion from a previous range of $1.850 billion to $1.876 billion, which was below analysts' expectations. The company also projected a net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. This announcement led to a stock price drop of $35.22 per share, or over 32%, from $109.11 to $73.89 [6].

Core Viewpoint - A class action securities lawsuit has been filed against Integer Holdings Corporation, alleging securities fraud that affected investors between July 25, 2024, and October 22, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Integer Holdings Corporation materially overstated its competitive position in the electrophysiology manufacturing market [2]. - It is alleged that despite claims of strong visibility into customer demand, the company was experiencing a sustained deterioration in sales related to two of its electrophysiology devices [2]. - The complaint further asserts that Integer mischaracterized its electrophysiology devices as a long-term growth driver for its cardio & vascular segment, leading to materially false and misleading statements about the company's business and prospects [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the relevant time frame have until February 9, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a track record of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - Integer Holdings Corporation is facing a securities fraud class action lawsuit due to allegations of misleading statements regarding its competitive position and sales performance in the EP manufacturing market [2]. Group 1: Lawsuit Details - The lawsuit claims that from July 25, 2024, to October 22, 2025, Integer failed to disclose that it materially overstated its competitive position in the EP manufacturing market [2]. - The complaint alleges that despite Integer's assertions of strong visibility into customer demand, the company was experiencing a sustained decline in sales related to two of its EP devices [2]. - Integer mischaracterized its EP devices as a long-term growth driver for its C&V segment, leading to materially misleading statements about the company's business and prospects [2]. Group 2: Investor Participation - Investors who suffered losses related to Integer Holdings Corporation have the opportunity to lead the class action lawsuit, with a deadline for participation set for February 9, 2026 [1][2]. - Interested investors can contact the Law Offices of Frank R. Cruz for more information or to participate in the lawsuit [3].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation for allegedly misleading investors regarding its business performance and sales guidance [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Integer securities between July 25, 2024, and October 22, 2025 [1][2]. - Investors have until February 9, 2026, to seek appointment as lead plaintiff representative [2]. Group 2: Allegations Against Integer - The company is accused of overstating its competitive position and failing to disclose declining sales of electrophysiology devices [3]. - Integer mischaracterized its growth drivers, leading to misleading representations about its business [3]. Group 3: Impact on Stock Price - On October 23, 2025, Integer lowered its sales guidance, resulting in a stock price drop of $35.22 per share, which is over 32% in a single trading day [4].

Core Viewpoint - A class action securities lawsuit has been filed against Integer Holdings Corporation, alleging securities fraud that negatively impacted investors between July 25, 2024, and October 22, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Integer Holdings materially overstated its competitive position in the electrophysiology manufacturing market [2]. - It is alleged that despite claims of strong customer demand visibility, the company faced a sustained decline in sales for two of its electrophysiology devices [2]. - The company mischaracterized its electrophysiology devices as long-term growth drivers for its cardio & vascular segment, leading to misleading positive statements about its business and prospects [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until February 9, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, titled West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251 [3]. - Investors have until February 9, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - Integer Holdings Corporation designs and manufactures cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. - The company had previously claimed strong sales growth and market position for its EP devices, which is now being challenged [4]. Group 3: Financial Performance - Integer lowered its 2025 sales guidance to a range of $1.840 billion to $1.854 billion, down from $1.850 billion to $1.876 billion, which is below analysts' expectations [6]. - The company anticipates poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026 [6]. - Following the announcement, Integer's stock price fell by $35.22 per share, a decline of over 32%, from $109.11 on October 22, 2025, to $73.89 on October 23, 2025 [6][5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Integer Holdings Corporation during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Integer common stock between July 25, 2024, and October 22, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 9, 2026 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Integer Holdings Corporation made materially false and misleading statements regarding its competitive position in the electrophysiology manufacturing market and the performance of its EP devices [5]. - It is claimed that Integer misrepresented its EP devices as a long-term growth driver, leading to misleading positive statements about its business and operations [5].

Core Viewpoint - Integer Holdings Corporation (NYSE: ITGR) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its competitive position and sales performance in the electrophysiology manufacturing market [3]. Group 1: Allegations - The complaint alleges that Integer overstated its competitive position within the growing electrophysiology manufacturing market [3]. - Despite claims of strong visibility into customer demand, the company was experiencing a sustained deterioration in sales related to two of its electrophysiology devices [3]. - Integer mischaracterized its electrophysiology devices as a long-term growth driver for its cardio & vascular segment [3]. - As a result, the positive statements made by the defendants about the company's business, operations, and prospects were materially false and misleading [3]. Group 2: Class Action Details - The class period for the lawsuit is from July 25, 2024, to October 22, 2025 [3]. - Shareholders who purchased shares during this period are encouraged to register for the class action, with a deadline to seek lead plaintiff status set for February 9, 2026 [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and engage in good corporate citizenship [5].

Core Viewpoint - Integer Holdings Corporation has faced significant challenges, leading to a reduction in its sales guidance for 2025 and a negative outlook for 2026, which has resulted in a substantial decline in its stock price [2][3]. Financial Performance - On October 23, 2025, Integer reduced its full-year 2025 sales guidance to a range of $1.840 billion to $1.854 billion, which is below prior expectations [2]. - The company anticipates net sales growth of –2% to 2% and organic sales growth of 0% to 4% for 2026 [2]. Product Performance - Management indicated that sales of three new products, including two electrophysiology devices, are expected to decline in 2026 due to slower market adoption than forecasted [2]. - The Cardio & Vascular sales growth is expected to decelerate, primarily due to declines in the electrophysiology products, with this impact continuing into 2026 [2]. Stock Market Reaction - Following the announcement of the reduced sales guidance, Integer's stock price fell by $35.22 per share, or 32.3%, closing at $73.89 per share on October 23, 2025 [3]. Legal Proceedings - A class action lawsuit has been filed alleging that Integer made materially false and misleading statements regarding its business and operations during the class period from July 25, 2024, to October 22, 2025 [4]. - The lawsuit claims that Integer overstated its competitive position in the electrophysiology manufacturing market and mischaracterized its EP devices as long-term growth drivers [4].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations of Securities Fraud - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had reportedly fallen sharply, contradicting the company's public statements about sales growth and market position [5][4]. Stock Price Decline - On October 23, 2025, Integer revised its 2025 sales guidance down to a range of $1.840 billion to $1.854 billion from a previous range of $1.850 billion to $1.876 billion, which was below analysts' expectations. The company also projected a poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. This announcement led to a stock price drop of $35.22 per share, over 32%, from $109.11 to $73.89 [6]. Legal Proceedings - Investors have until February 9, 2026, to request to lead the case in the U.S. District Court for the Southern District of New York, under the case caption West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al. [3]. Legal Representation - Bleichmar Fonti & Auld LLP, a leading law firm in securities class actions, is representing the plaintiffs in this case, emphasizing that there are no costs to shareholders for litigation [7][8].